Font Size: a A A
Keyword [DLBCL]
Result: 21 - 40 | Page: 2 of 10
21. The Correlation Of GC-type DLBCL With Acquired Somatic Mutations In Non Coding Region Of BCL6
22. Mechanism And Clinical Significance Of Anti-apoptotic Gene BCL2 Expression In Diffuse Large B-Cell Lymphoma
23. The Clinical Features And Prognostic Factors Of DLBCL And Its Significance
24. SIRT1 Protein Expression And Gene Status In DLBCL And Its Effects On Biologic Behaviour Of DLBCL Cell Lines
25. Expressions Of TNF-α,TNF-β And PKC-βⅡ In Diffuse Large B-cell Lymphoma And Its Significance
26. The Clinical Features And Prognostic Analysis Of Patients With Diffuse Large B-cell Lymphoma(DLBCL)
27. The Correlation Of Immunophenotyping Of DLBCL With Choi's And Hans Clasification To The Prognosis
28. Clinical Significance Of Expressions Of Bcl-2 And BCRP In Diffuse Large B Cell Lymphoma
29. The Expression Of FOXP3~+ Treg And IL-10 And Correlation To Prognosis In DLBCL
30. The Correlation Of Bcl-2, C-myc And DLBCL Subtypes, Clinical Prognosis And Its Significance
31. Expressions Of PDE4B, BCL-2 And CD5 In Distinuished Type Non-Hodgkins Lymphoma And Its Significance
32. Evaluation Of The Prognosis Of Diffuse Large B-cell Lymphoma Using Mid-term 18 F-FDG PET / CT And Deauville Scoring Criteria
33. Expressions Of Pde4b, Bcl-2 And Cd5 In Distinuished Type Non-hodgkins Lymphoma And Its Significance
34. Compare The Pathologic Features Between Orbit And Systemic Diffuse Large B Cell Lymphoma And The Preliminary Establishment Of Orbital Diffuse Large B Cell Lymphoma's Mice Model
35. Study On Immunephenotype, Antiapoptotic Properties And PI3K/Akt/mTOR Signalling Mechanism In Uygur Diffuse Large B Cell Lymphoma In Xinjiang
36. IL-6Secreted By Tumor Associated Macrophages Promotes DLBCL Chemoresistance Via Expansion Of The CSCs Population
37. The Regulatory Effect And Underlying Mechanism Of JMJD3in Promoting Progress Of Diffuse Large B-cell Lymphoma
38. Prognostic Values Of Novel Molecules In NF-κB Pathway Among Peripheral T Cell Lymphoma And Diffuse Large B Cell Lymphoma
39. The Impact Of Expression Of Costimulatory Molecules In Peripheral Blood T Cells Among The Patients With DLBCL
40. Clinical Significance Of Aberrant Genetic Alterations In Large B Cell Lymphomas
  <<First  <Prev  Next>  Last>>  Jump to